New Antidepressant Drugs: Beyond Monoaminergic Mechanisms

被引：13

作者：

Alamo, Cecilio ^{[1
]}

Lopez-Munoz, Francisco ^{[1
]}

机构：

[1] Univ Alcala de Henares, Dept Pharmacol, Ctra Madrid Barcelona, Alcala De Henares 28871, Spain

来源：

CURRENT PHARMACEUTICAL DESIGN | 2009年 / 15卷 / 14期

关键词：

DISCOVERY; RECEPTORS; TARGET;

D O I：

10.2174/138161209788168047

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1559 / 1562

页数：4

共 19 条

[1]

ALAMO C, 2001, DIAGNOSTICO DIFERENC, P87

[2]

ALAMO C, 2004, MONOGRAFIA REAL ACAD, V15, P351

[3]

Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21

[4]

[Anonymous], DEPR

[5] Opiates as Antidepressants [J].

Berrocoso, Esther ;

Sanchez-Blazquez, Pilar ;

Garzon, Javier ;

Mico, Juan A. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (14) :1612-1622

[6] New approaches to antidepressant drug discovery: beyond monoamines [J].

Berton, O ;

Nestler, EJ .

NATURE REVIEWS NEUROSCIENCE, 2006, 7 (02) :137-151

[7] Melatonin Receptor Agonist Agomelatine: A New Drug for Treating Unipolar Depression [J].

Bourin, Michel ;

Prica, Corina .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (14) :1675-1682

[8] Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders [J].

Ebner, Karl ;

Sartori, Simone B. ;

Singewald, Nicolas .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (14) :1647-1674

[9] Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions [J].

Golan, Moran ;

Schreiber, Gabriel ;

Avissar, Sofia .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (14) :1699-1708

[10]

Lopez-Munoz F., 2008, PSIQUIATR BIOL, V15, P125

← 1 2 →